FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Research Reports

We recently teamed up with the researchers at Datamonitor to provide the Fierce community with access to the latest in paid Biotech and Pharmaceutical industry intelligence. You can search for in-depth pipeline reports, competitor profiles, analysis of key trends and more at the following link:

Datamonitor Report Center-

We have also hand selected some reports that you may find of interest. You can see them below:


Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments

Date Published:
June 2008
Price:
$3835
Source:
Business Insights

Identify key trends and developments in the global drug delivery market, assess the performances and portfolios of leading drug delivery companies and benchmark their strategies with this new report...

Drug Repositioning Strategies - Serendipity by design

Date Published:
08-May-08
Price:
$3,800.00
Source:
Datamonitor

Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment.

eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process

Date Published:
23-May-08
Price:
$3,800.00
Source:
Datamonitor

Optimizing the recruitment process through web-based technologies can cut delays in clinical trials and can also be used to maintain relationships with patients to improve the clinical trial process.

 

 

Pricing & Reimbursement - Seven Major Markets Update

Date Published:
28-May-08
Price:
$5,700.00
Source:
Datamonitor

Review recent P&R trends in the seven major markets based on Datamonitor analysis and primary research conducted with key stakeholders in the industry.

Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

Date Published:
May-08
Price:
$3,835.00
Source:
Business Insights

Innovative Clinical Trial Design and Management is a report published by Business Insights that explores the major types of adaptive design and their role in dose-finding.

The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

Date Published:
May-08
Price:
$3,835.00
Source:
Business Insights

Emerging Role of Postmarketing Clinical Research is a report published by Business Insights that uses detailed case studies and market scenarios to examine the latest issues surrounding phase IV trial applications.

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors

Date Published:
May-08
Price:
$3,835.00
Source:
Business Insights

Contract Manufacturing Strategies is a report published by Business Insights that explores the future of the contract manufacturing market with a detailed analysis of emerging drivers and restraints, business models and production strategies.

Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?

Date Published:
17-Apr-08
Price:
$11,400
Source:
Datamonitor

This report assesses the clinical pipeline candidates five key nosocomial pathogens and their potential market environment including target population size estimates.

Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response

Date Published:
April 2008
Price:
$3,835
Source:
Business Insights

Understand the changing landscape for FDA and EMEA drug approvals, discover the implications of process changes upon your drug applications and anticipate future regulatory developments with this new report...

Biotech 2008 – life sciences industry report (online & print)

Price:
$680.00
Source:
Burrill Life Sciences Media Group

Biotech 2008 22nd annual report enables anyone in life sciences to gain a global view on industry financials, key sector activities, important technologies, policies and politics, analysis of deal making, capital markets and so much more.